Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 10 Show results per page	View Search Criteria \| Help With Results

Last Modified: 5/22/2008 First Published: 5/23/2005


1.		Phase III Randomized Study of Cytarabine With Versus Without VNP40101M in Patients With Acute Myeloid Leukemia in First Relapse

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Temporarily closed				18 and over				Pharmaceutical / Industry				VION-CLI-037 NCT00112554

Last Modified: 8/22/2008 First Published: 3/13/2006


2.		Phase I/II Study of VNP40101M in Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				Pharmaceutical / Industry				VION-CLI-041 MDA-2005-0249, NCT00304005

Last Modified: 8/22/2008 First Published: 4/16/2004


3.		Phase II Study of VNP40101M in Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				VION-CLI-033 NCT00083187

Last Modified: 12/17/2007 First Published: 1/20/2006


4.		Phase II Study of VNP40101M in Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				VION-CLI-039 NCT00282022

Last Modified: 1/26/2006 First Published: 10/1/2001


5.		Phase I Study of VNP40101M in Patients With Advanced Solid Tumors or Lymphomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				Pharmaceutical / Industry				VION-CLI-011 NCI-V01-1669, NCT00025129

Last Modified: 12/28/2007 First Published: 11/1/2002


6.		Phase I Study of VNP40101M in Patients With Relapsed or Refractory Leukemia or Poor-Risk Myelodysplastic Syndromes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				Pharmaceutical / Industry				VION-CLI-029 MDA-DM-02202, NCT00049686

Last Modified: 12/28/2007 First Published: 11/1/2002


7.		Phase I Study of VNP40101M in Patients With Advanced or Metastatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				Pharmaceutical / Industry				VION-CLI-028 YALE-HIC-16775, NCT00049699

Last Modified: 8/22/2008 First Published: 9/24/2003


8.		Phase I Study of VNP40101M and Cytarabine in Patients With Hematologic Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI, Pharmaceutical / Industry				VION-CLI-034 MDA-2003-0326, NCT00070538

Last Modified: 2/21/2008 First Published: 11/22/2004


9.		Phase I Study of VNP40101M in Pediatric Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				21 and under				NCI, Pharmaceutical / Industry				PBTC-017 PBTC-017, VION-VNP40101M, NCT00098761

Last Modified: 8/22/2008 First Published: 11/15/2004


10.		Phase I Study of Temozolomide and VNP40101M in Patients With Relapsed or Refractory Leukemias

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				Pharmaceutical / Industry				VION-CLI-036 CWRU-050419, NCT00098436

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute